Bristol Myers Squibb Enhances Neuroscience Portfolio Through $14 Billion Karuna Therapeutics Acquisition
American multinational pharmaceutical company Bristol Myers Squibb and Karuna Therapeutics, Inc. (“Karuna”) have announced that they have entered into a
Read more